Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

Sinthuja Pachchek; Zied Landoulsi; Lukas Pavelka; Claudia Schulte; Elena Buena-Atienza; Caspar Gross; Ann Kathrin Hauser; Dheeraj Reddy Bobbili; Nicolas Casadei; Patrick May; Rejko Krüger; Geeta Acharya; Gloria Aguayo; Myriam Alexandre; Muhammad Ali; Wim Ammerlann; Giuseppe Arena; Rudi Balling; Michele Bassis; Roxane Batutu; Katy Beaumont; Regina Becker; Camille Bellora; Guy Berchem; Daniela Berg; Alexandre Bisdorff; Ibrahim Boussaad; David Bouvier; Kathrin Brockmann; Jessica Calmes; Lorieza Castillo; Gessica Contesotto; Nancy De Bremaeker; Nico Diederich; Rene Dondelinger; Nancy E. Ramia; Daniela Esteves; Guy Fagherazzi; Jean Yves Ferrand; Katrin Frauenknecht; Manon Gantenbein; Thomas Gasser; Piotr Gawron; Soumyabrata Ghosh; Marijus Giraitis; Enrico Glaab; Martine Goergen; Elisa Gómez De Lope; Jérôme Graas; Anne Marie Hanff; NCER-PD Consortium

doi:10.1038/s41531-023-00613-x

Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

Sinthuja Pachchek^*, Zied Landoulsi, Lukas Pavelka, Claudia Schulte, Elena Buena-Atienza, Caspar Gross, Ann Kathrin Hauser, Dheeraj Reddy Bobbili, Nicolas Casadei, Patrick May^*, Rejko Krüger^*, Geeta Acharya, Gloria Aguayo, Myriam Alexandre, Muhammad Ali, Wim Ammerlann, Giuseppe Arena, Rudi Balling, Michele Bassis, Roxane BatutuKaty Beaumont, Regina Becker, Camille Bellora, Guy Berchem, Daniela Berg, Alexandre Bisdorff, Ibrahim Boussaad, David Bouvier, Kathrin Brockmann, Jessica Calmes, Lorieza Castillo, Gessica Contesotto, Nancy De Bremaeker, Nico Diederich, Rene Dondelinger, Nancy E. Ramia, Daniela Esteves, Guy Fagherazzi, Jean Yves Ferrand, Katrin Frauenknecht, Manon Gantenbein, Thomas Gasser, Piotr Gawron, Soumyabrata Ghosh, Marijus Giraitis, Enrico Glaab, Martine Goergen, Elisa Gómez De Lope, Jérôme Graas, Anne Marie Hanff, NCER-PD Consortium

^*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum › Academic

Abstract

npj Parkinson’s Disease, published online 23 November 2023 In this article the wrong Table appeared as Table 3.; the Table should have appeared as shown below. The original article has been corrected. The following text that describes data from the previous version of Table 3 has also been removed: “Compared to severe (6.4 ± 4.7) and risk (4.4 ± 4.9) variant carriers, the mild (1.7 ± 1.4) variant carriers show a significantly shorter disease duration (Table 3).” (Table presented.) Features All pathogenic variants (n = 67) Severe (n = 21) Mild (n = 7) Risk (n = 39) Non carriers (n = 554) AAA, mean (SD) 66.5 (±10.2) [OR = 0.31; p = 0.3977] 65.1 (±10.2) [OR = 0.08; p = 0.292] 67.1 (±15.6) [OR = 0.59; p = 0.8959] 67.1 (±9.2) [OR = 0.57; p = 0.7512] 67.6 (±10.7) Sex, Male n (%) 40 (59.7%) [OR = 0.71; p = 0.1912] 13 (61.9%) [OR = 0.78; p = 0.5795] 5 (71.4%) [OR = 1.19; p = 0.8336] 22 (56.4%) [OR = 0.62; p = 0.151] 375 (67.7%) AAO, mean (SD) 61.6 (±11.5) [OR = 0.35; p = 0.484] 58.6 (±13.1) [OR = 0.02; p = 0.1158] 65.4 (±17.0) [OR = 16.16; p = 0.5308] 62.5 (±9.3) [OR = 0.9; p = 0.9548] 62.6 (±11.6) AAO < 45, N (%) 8 (11.9%) [OR = 1.74; p = 0.1767] 2 (28.6%) [OR = 5.14; p = 0.0549] 1 (2.6%) [OR = 0.34; p = 0.2907] 40 (7.2%) Disease Duration, mean (SD) 4.7 (±4.8) [OR = 0.79; p = 0.7303] 6.4 (±4.7) [OR = 4.07; p = 0.2238] 1.7 (±1.4) [OR = 0.04; p =0.0981] 4.4 (±4.9) [OR = 0.57; p = 0.5103] 5.0 (±5.2) Family History, N (%) 8 (38.1%) [OR = 1.8; p = 0.2001] 2 (28.6% [OR = 1.17; p = 0.8508] 15 (38.5%) [OR = 1.83; p = 0.0782] 141 (25.5%).

Original language	English
Article number	168
Number of pages	1
Journal	npj Parkinson's Disease
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41531-023-00613-x
Publication status	Published - 18 Dec 2023

Access to Document

10.1038/s41531-023-00613-xLicence: CC BY

1 Article

Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
Pachchek, S., Landoulsi, Z., Pavelka, L., Schulte, C., Buena-Atienza, E., Gross, C., Hauser, A. K., Reddy Bobbili, D., Casadei, N., May, P., Krüger, R., Acharya, G., Aguayo, G., Alexandre, M., Ali, M., Ammerlann, W., Arena, G., Balling, R., Bassis, M. & Batutu, R. & 31 others, Beaumont, K., Becker, R., Bellora, C., Berchem, G., Berg, D., Bisdorff, A., Boussaad, I., Bouvier, D., Brockmann, K., Calmes, J., Castillo, L., Contesotto, G., De Bremaeker, N., Diederich, N., Dondelinger, R., E. Ramia, N., Esteves, D., Fagherazzi, G., Ferrand, J. Y., Frauenknecht, K., Gantenbein, M., Gasser, T., Gawron, P., Ghosh, S., Giraitis, M., Glaab, E., Goergen, M., Gómez De Lope, E., Graas, J., Hanff, A. M. & NCER-PD Consortium, 23 Nov 2023, In: npj Parkinson's Disease. 9, 1, 14 p., 156.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Cite this

Pachchek, S., Landoulsi, Z., Pavelka, L., Schulte, C., Buena-Atienza, E., Gross, C., Hauser, A. K., Reddy Bobbili, D., Casadei, N., May, P., Krüger, R., Acharya, G., Aguayo, G., Alexandre, M., Ali, M., Ammerlann, W., Arena, G., Balling, R., Bassis, M., ... NCER-PD Consortium (2023). Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study. npj Parkinson's Disease, 9(1), Article 168. https://doi.org/10.1038/s41531-023-00613-x

@article{d929ad224ab14dac98ce71755d617c64,

title = "Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson{\textquoteright}s study",

abstract = "npj Parkinson{\textquoteright}s Disease, published online 23 November 2023 In this article the wrong Table appeared as Table 3.; the Table should have appeared as shown below. The original article has been corrected. The following text that describes data from the previous version of Table 3 has also been removed: “Compared to severe (6.4 ± 4.7) and risk (4.4 ± 4.9) variant carriers, the mild (1.7 ± 1.4) variant carriers show a significantly shorter disease duration (Table 3).” (Table presented.) Features All pathogenic variants (n = 67) Severe (n = 21) Mild (n = 7) Risk (n = 39) Non carriers (n = 554) AAA, mean (SD) 66.5 (±10.2) [OR = 0.31; p = 0.3977] 65.1 (±10.2) [OR = 0.08; p = 0.292] 67.1 (±15.6) [OR = 0.59; p = 0.8959] 67.1 (±9.2) [OR = 0.57; p = 0.7512] 67.6 (±10.7) Sex, Male n (\%) 40 (59.7\%) [OR = 0.71; p = 0.1912] 13 (61.9\%) [OR = 0.78; p = 0.5795] 5 (71.4\%) [OR = 1.19; p = 0.8336] 22 (56.4\%) [OR = 0.62; p = 0.151] 375 (67.7\%) AAO, mean (SD) 61.6 (±11.5) [OR = 0.35; p = 0.484] 58.6 (±13.1) [OR = 0.02; p = 0.1158] 65.4 (±17.0) [OR = 16.16; p = 0.5308] 62.5 (±9.3) [OR = 0.9; p = 0.9548] 62.6 (±11.6) AAO < 45, N (\%) 8 (11.9\%) [OR = 1.74; p = 0.1767] 2 (28.6\%) [OR = 5.14; p = 0.0549] 1 (2.6\%) [OR = 0.34; p = 0.2907] 40 (7.2\%) Disease Duration, mean (SD) 4.7 (±4.8) [OR = 0.79; p = 0.7303] 6.4 (±4.7) [OR = 4.07; p = 0.2238] 1.7 (±1.4) [OR = 0.04; p =0.0981] 4.4 (±4.9) [OR = 0.57; p = 0.5103] 5.0 (±5.2) Family History, N (\%) 8 (38.1\%) [OR = 1.8; p = 0.2001] 2 (28.6\% [OR = 1.17; p = 0.8508] 15 (38.5\%) [OR = 1.83; p = 0.0782] 141 (25.5\%).",

author = "Sinthuja Pachchek and Zied Landoulsi and Lukas Pavelka and Claudia Schulte and Elena Buena-Atienza and Caspar Gross and Hauser, \{Ann Kathrin\} and \{Reddy Bobbili\}, Dheeraj and Nicolas Casadei and Patrick May and Rejko Kr{\"u}ger and Geeta Acharya and Gloria Aguayo and Myriam Alexandre and Muhammad Ali and Wim Ammerlann and Giuseppe Arena and Rudi Balling and Michele Bassis and Roxane Batutu and Katy Beaumont and Regina Becker and Camille Bellora and Guy Berchem and Daniela Berg and Alexandre Bisdorff and Ibrahim Boussaad and David Bouvier and Kathrin Brockmann and Jessica Calmes and Lorieza Castillo and Gessica Contesotto and \{De Bremaeker\}, Nancy and Nico Diederich and Rene Dondelinger and \{E. Ramia\}, Nancy and Daniela Esteves and Guy Fagherazzi and Ferrand, \{Jean Yves\} and Katrin Frauenknecht and Manon Gantenbein and Thomas Gasser and Piotr Gawron and Soumyabrata Ghosh and Marijus Giraitis and Enrico Glaab and Martine Goergen and \{G{\'o}mez De Lope\}, Elisa and J{\'e}r{\^o}me Graas and Hanff, \{Anne Marie\} and \{NCER-PD Consortium\}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

day = "18",

doi = "10.1038/s41531-023-00613-x",

language = "English",

volume = "9",

journal = "npj Parkinson's Disease",

issn = "2373-8057",

publisher = "Springer Nature",

number = "1",

}

Pachchek, S, Landoulsi, Z, Pavelka, L, Schulte, C, Buena-Atienza, E, Gross, C, Hauser, AK, Reddy Bobbili, D, Casadei, N, May, P, Krüger, R, Acharya, G, Aguayo, G, Alexandre, M, Ali, M, Ammerlann, W, Arena, G, Balling, R, Bassis, M, Batutu, R, Beaumont, K, Becker, R, Bellora, C, Berchem, G, Berg, D, Bisdorff, A, Boussaad, I, Bouvier, D, Brockmann, K, Calmes, J, Castillo, L, Contesotto, G, De Bremaeker, N, Diederich, N, Dondelinger, R, E. Ramia, N, Esteves, D, Fagherazzi, G, Ferrand, JY, Frauenknecht, K, Gantenbein, M, Gasser, T, Gawron, P, Ghosh, S, Giraitis, M, Glaab, E, Goergen, M, Gómez De Lope, E, Graas, J, Hanff, AM & NCER-PD Consortium 2023, 'Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study', npj Parkinson's Disease, vol. 9, no. 1, 168. https://doi.org/10.1038/s41531-023-00613-x

TY - JOUR

T1 - Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

AU - Pachchek, Sinthuja

AU - Landoulsi, Zied

AU - Pavelka, Lukas

AU - Schulte, Claudia

AU - Buena-Atienza, Elena

AU - Gross, Caspar

AU - Hauser, Ann Kathrin

AU - Reddy Bobbili, Dheeraj

AU - Casadei, Nicolas

AU - May, Patrick

AU - Krüger, Rejko

AU - Acharya, Geeta

AU - Aguayo, Gloria

AU - Alexandre, Myriam

AU - Ali, Muhammad

AU - Ammerlann, Wim

AU - Arena, Giuseppe

AU - Balling, Rudi

AU - Bassis, Michele

AU - Batutu, Roxane

AU - Beaumont, Katy

AU - Becker, Regina

AU - Bellora, Camille

AU - Berchem, Guy

AU - Berg, Daniela

AU - Bisdorff, Alexandre

AU - Boussaad, Ibrahim

AU - Bouvier, David

AU - Brockmann, Kathrin

AU - Calmes, Jessica

AU - Castillo, Lorieza

AU - Contesotto, Gessica

AU - De Bremaeker, Nancy

AU - Diederich, Nico

AU - Dondelinger, Rene

AU - E. Ramia, Nancy

AU - Esteves, Daniela

AU - Fagherazzi, Guy

AU - Ferrand, Jean Yves

AU - Frauenknecht, Katrin

AU - Gantenbein, Manon

AU - Gasser, Thomas

AU - Gawron, Piotr

AU - Ghosh, Soumyabrata

AU - Giraitis, Marijus

AU - Glaab, Enrico

AU - Goergen, Martine

AU - Gómez De Lope, Elisa

AU - Graas, Jérôme

AU - Hanff, Anne Marie

AU - NCER-PD Consortium

PY - 2023/12/18

Y1 - 2023/12/18

N2 - npj Parkinson’s Disease, published online 23 November 2023 In this article the wrong Table appeared as Table 3.; the Table should have appeared as shown below. The original article has been corrected. The following text that describes data from the previous version of Table 3 has also been removed: “Compared to severe (6.4 ± 4.7) and risk (4.4 ± 4.9) variant carriers, the mild (1.7 ± 1.4) variant carriers show a significantly shorter disease duration (Table 3).” (Table presented.) Features All pathogenic variants (n = 67) Severe (n = 21) Mild (n = 7) Risk (n = 39) Non carriers (n = 554) AAA, mean (SD) 66.5 (±10.2) [OR = 0.31; p = 0.3977] 65.1 (±10.2) [OR = 0.08; p = 0.292] 67.1 (±15.6) [OR = 0.59; p = 0.8959] 67.1 (±9.2) [OR = 0.57; p = 0.7512] 67.6 (±10.7) Sex, Male n (%) 40 (59.7%) [OR = 0.71; p = 0.1912] 13 (61.9%) [OR = 0.78; p = 0.5795] 5 (71.4%) [OR = 1.19; p = 0.8336] 22 (56.4%) [OR = 0.62; p = 0.151] 375 (67.7%) AAO, mean (SD) 61.6 (±11.5) [OR = 0.35; p = 0.484] 58.6 (±13.1) [OR = 0.02; p = 0.1158] 65.4 (±17.0) [OR = 16.16; p = 0.5308] 62.5 (±9.3) [OR = 0.9; p = 0.9548] 62.6 (±11.6) AAO < 45, N (%) 8 (11.9%) [OR = 1.74; p = 0.1767] 2 (28.6%) [OR = 5.14; p = 0.0549] 1 (2.6%) [OR = 0.34; p = 0.2907] 40 (7.2%) Disease Duration, mean (SD) 4.7 (±4.8) [OR = 0.79; p = 0.7303] 6.4 (±4.7) [OR = 4.07; p = 0.2238] 1.7 (±1.4) [OR = 0.04; p =0.0981] 4.4 (±4.9) [OR = 0.57; p = 0.5103] 5.0 (±5.2) Family History, N (%) 8 (38.1%) [OR = 1.8; p = 0.2001] 2 (28.6% [OR = 1.17; p = 0.8508] 15 (38.5%) [OR = 1.83; p = 0.0782] 141 (25.5%).

AB - npj Parkinson’s Disease, published online 23 November 2023 In this article the wrong Table appeared as Table 3.; the Table should have appeared as shown below. The original article has been corrected. The following text that describes data from the previous version of Table 3 has also been removed: “Compared to severe (6.4 ± 4.7) and risk (4.4 ± 4.9) variant carriers, the mild (1.7 ± 1.4) variant carriers show a significantly shorter disease duration (Table 3).” (Table presented.) Features All pathogenic variants (n = 67) Severe (n = 21) Mild (n = 7) Risk (n = 39) Non carriers (n = 554) AAA, mean (SD) 66.5 (±10.2) [OR = 0.31; p = 0.3977] 65.1 (±10.2) [OR = 0.08; p = 0.292] 67.1 (±15.6) [OR = 0.59; p = 0.8959] 67.1 (±9.2) [OR = 0.57; p = 0.7512] 67.6 (±10.7) Sex, Male n (%) 40 (59.7%) [OR = 0.71; p = 0.1912] 13 (61.9%) [OR = 0.78; p = 0.5795] 5 (71.4%) [OR = 1.19; p = 0.8336] 22 (56.4%) [OR = 0.62; p = 0.151] 375 (67.7%) AAO, mean (SD) 61.6 (±11.5) [OR = 0.35; p = 0.484] 58.6 (±13.1) [OR = 0.02; p = 0.1158] 65.4 (±17.0) [OR = 16.16; p = 0.5308] 62.5 (±9.3) [OR = 0.9; p = 0.9548] 62.6 (±11.6) AAO < 45, N (%) 8 (11.9%) [OR = 1.74; p = 0.1767] 2 (28.6%) [OR = 5.14; p = 0.0549] 1 (2.6%) [OR = 0.34; p = 0.2907] 40 (7.2%) Disease Duration, mean (SD) 4.7 (±4.8) [OR = 0.79; p = 0.7303] 6.4 (±4.7) [OR = 4.07; p = 0.2238] 1.7 (±1.4) [OR = 0.04; p =0.0981] 4.4 (±4.9) [OR = 0.57; p = 0.5103] 5.0 (±5.2) Family History, N (%) 8 (38.1%) [OR = 1.8; p = 0.2001] 2 (28.6% [OR = 1.17; p = 0.8508] 15 (38.5%) [OR = 1.83; p = 0.0782] 141 (25.5%).

U2 - 10.1038/s41531-023-00613-x

DO - 10.1038/s41531-023-00613-x

M3 - Erratum / corrigendum

SN - 2373-8057

VL - 9

JO - npj Parkinson's Disease

JF - npj Parkinson's Disease

IS - 1

M1 - 168

ER -

Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

Abstract

Access to Document

Fingerprint

Research output

Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

Cite this